XML 70 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Dispositions (Details Textual)
$ in Millions
1 Months Ended 3 Months Ended
Apr. 30, 2022
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2022
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Equity, ownership interest   49.90%     49.90%
Equity Method Investment, Amount Sold $ 2,300.0        
Samsung Bioepis | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Other current assets, receivable   $ 436.1   $ 430.0  
Samsung Bioepis | Payment Due At First Anniversary | Discount rates | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Risk-adjusted discount rates   0.060      
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestiture of interest in joint venture 1,000.0        
Payables to divestiture of interest in joint venture 1,300.0        
Samsung Bioepis | Payment Due At First Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture 812.5        
Gain (loss) on sale     $ 11.1    
Samsung Bioepis | Payment Due At Second Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture $ 437.5        
Gain (loss) on sale   $ 6.1 $ 6.2